Skip to main content
Top
Published in: BMC Neurology 1/2024

Open Access 01-12-2024 | Headache | Research

Questionnaire-based study of COVID-19 vaccination induced headache: evidence of clusters of adverse events

Authors: Qiao Zhou, Thomas Eggert, Ana Zhelyazkova, Alexander Choukér, Kristina Adorjan, Andreas Straube

Published in: BMC Neurology | Issue 1/2024

Login to get access

Abstract

Background

The adverse events (AEs) after a Coronavirus disease 2019 (Covid-19) Pfizer-Biotech mRNA vaccination present a medical and epidemiological issue of increasing interest. Headache is the most frequent neurological adverse effect and generally the third most common adverse event after a Covid-19 vaccination, but only a few studies focus on the link between headache and other AEs after vaccination. This study aims to investigate the correlation between headaches and Covid-19 vaccination, as well as the possible links between headaches and other AEs after Covid-19 vaccination, thereby helping the management of AEs and avoiding further occurrences.

Methods

This study is based on a published questionnaire survey of 1,402 healthcare workers. Our study focused on the 5 questions including 12 AEs and headaches extracted from the questionnaire post the first and second Covid-19 vaccination. The severity of the 12 AEs and headaches could be classified by the participants on a five-step scale: “Not at all”, “Little”, “Average”, “Quite”, and “Very” (abbreviated as “N”, “L”, “A”, “Q”, “V”). We used the Bowker test to study the comparison of headache severity, indicated on a 5-point Likert scale between the first and second vaccinations. We applied an ordinal logistic regression to the 5 categories with headache severity serving as the dependent variable and the ratings of the other 12 AEs serving as the independent variable to further explore to what extent the severity of the 12 AEs is associated with the severity of headaches. Receiver Operating Characteristic (ROC) analysis was conducted to evaluate the predictive value of the ratings of the 12 AEs to headache severity.

Results

We found that participants rated their headaches as more severe after the second vaccination, and participants who reported experiencing fatigue, flu-like symptoms, pain at the injection site, known tension-type headache, fever, dizziness/balance problems and known migraine are associated with headache symptoms.

Conclusions

There are clusters of headache-associated AEs post Covid-19 vaccination. The association of various AEs with headaches may be due to similar causative mechanisms.
Appendix
Available only for authorised users
Literature
2.
go back to reference Fiolet T, et al. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202–21.CrossRefPubMed Fiolet T, et al. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202–21.CrossRefPubMed
3.
go back to reference Shapiro B, David S et al. Immediate side effects of comirnaty COVID-19 vaccine: a nationwide survey of vaccinated people in Israel, December 2020 to March 2021. Euro Surveill. 2022;27(13). Shapiro B, David S et al. Immediate side effects of comirnaty COVID-19 vaccine: a nationwide survey of vaccinated people in Israel, December 2020 to March 2021. Euro Surveill. 2022;27(13).
4.
go back to reference Andrzejczak-Grządko S, Czudy Z, Donderska M. Side effects after COVID-19 vaccinations among residents of Poland. Eur Rev Med Pharmacol Sci. 2021;25(12):4418–21.PubMed Andrzejczak-Grządko S, Czudy Z, Donderska M. Side effects after COVID-19 vaccinations among residents of Poland. Eur Rev Med Pharmacol Sci. 2021;25(12):4418–21.PubMed
5.
go back to reference Sampaio Rocha-Filho PA, et al. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study. J Headache Pain. 2022;23(1):2.CrossRefPubMedPubMedCentral Sampaio Rocha-Filho PA, et al. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study. J Headache Pain. 2022;23(1):2.CrossRefPubMedPubMedCentral
6.
7.
go back to reference Al-Ali D, et al. Cardiovascular and haematological events post COVID-19 vaccination: a systematic review. J Cell Mol Med. 2022;26(3):636–53.MathSciNetCrossRefPubMed Al-Ali D, et al. Cardiovascular and haematological events post COVID-19 vaccination: a systematic review. J Cell Mol Med. 2022;26(3):636–53.MathSciNetCrossRefPubMed
8.
go back to reference Cocores AN, Goadsby PJ, Monteith TS. Post-vaccination headache reporting: trends according to the vaccine adverse events reporting system. Headache. 2023;63(2):275–82.CrossRefPubMed Cocores AN, Goadsby PJ, Monteith TS. Post-vaccination headache reporting: trends according to the vaccine adverse events reporting system. Headache. 2023;63(2):275–82.CrossRefPubMed
10.
go back to reference Castaldo M, et al. Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis. J Headache Pain. 2022;23(1):41.CrossRefPubMedPubMedCentral Castaldo M, et al. Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis. J Headache Pain. 2022;23(1):41.CrossRefPubMedPubMedCentral
11.
go back to reference Göbel CH, et al. Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study. Brain Commun. 2021;3(3):fcab169.ADSCrossRefPubMedPubMedCentral Göbel CH, et al. Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study. Brain Commun. 2021;3(3):fcab169.ADSCrossRefPubMedPubMedCentral
12.
go back to reference Chen L, et al. The association between adverse events of COVID-19 vaccination and anxiety and willingness to receive a booster dose. Hum Vaccin Immunother. 2023;19(1):2176643.CrossRefPubMedPubMedCentral Chen L, et al. The association between adverse events of COVID-19 vaccination and anxiety and willingness to receive a booster dose. Hum Vaccin Immunother. 2023;19(1):2176643.CrossRefPubMedPubMedCentral
13.
go back to reference García-Azorín D, et al. Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. J Headache Pain. 2021;22(1):108.CrossRefPubMedPubMedCentral García-Azorín D, et al. Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. J Headache Pain. 2021;22(1):108.CrossRefPubMedPubMedCentral
14.
go back to reference Zhelyazkova A et al. Are we prepared for the next pandemic? Management, systematic evaluation and lessons learned from an in-hospital COVID-19 vaccination centre for healthcare workers. Int J Environ Res Public Health. 2022;19(23). Zhelyazkova A et al. Are we prepared for the next pandemic? Management, systematic evaluation and lessons learned from an in-hospital COVID-19 vaccination centre for healthcare workers. Int J Environ Res Public Health. 2022;19(23).
15.
go back to reference Venables W, Ripley B. Modern applied statistics with S. Springer, New York: ISBN 0-387-95457-0. 2002. Venables W, Ripley B. Modern applied statistics with S. Springer, New York: ISBN 0-387-95457-0. 2002.
16.
go back to reference Sekiguchi K, et al. Incidence of headache after COVID-19 vaccination in patients with history of headache: a cross-sectional study. Cephalalgia. 2022;42(3):266–72.CrossRefPubMed Sekiguchi K, et al. Incidence of headache after COVID-19 vaccination in patients with history of headache: a cross-sectional study. Cephalalgia. 2022;42(3):266–72.CrossRefPubMed
17.
go back to reference Silvestro M et al. Headache worsening after COVID-19 vaccination: an online questionnaire-based study on 841 patients with migraine. J Clin Med. 2021;10(24). Silvestro M et al. Headache worsening after COVID-19 vaccination: an online questionnaire-based study on 841 patients with migraine. J Clin Med. 2021;10(24).
18.
go back to reference Göbel CH, et al. Headache attributed to vaccination against COVID-19 (coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study. Pain Ther. 2021;10(2):1309–30.CrossRefPubMedPubMedCentral Göbel CH, et al. Headache attributed to vaccination against COVID-19 (coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study. Pain Ther. 2021;10(2):1309–30.CrossRefPubMedPubMedCentral
19.
go back to reference Ekizoglu E, et al. The characteristics of COVID-19 vaccine-related headache: clues gathered from the healthcare personnel in the pandemic. Cephalalgia. 2022;42(4–5):366–75.CrossRefPubMed Ekizoglu E, et al. The characteristics of COVID-19 vaccine-related headache: clues gathered from the healthcare personnel in the pandemic. Cephalalgia. 2022;42(4–5):366–75.CrossRefPubMed
20.
go back to reference Boum Y, et al. Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study. Lancet Infect Dis. 2021;21(8):1089–96.CrossRefPubMedPubMedCentral Boum Y, et al. Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study. Lancet Infect Dis. 2021;21(8):1089–96.CrossRefPubMedPubMedCentral
21.
go back to reference Bolay H, et al. Are migraine patients at increased risk for symptomatic coronavirus disease 2019 due to shared comorbidities? Headache. 2020;60(10):2508–21.CrossRefPubMed Bolay H, et al. Are migraine patients at increased risk for symptomatic coronavirus disease 2019 due to shared comorbidities? Headache. 2020;60(10):2508–21.CrossRefPubMed
22.
go back to reference Trigo J, et al. Cytokine and interleukin profile in patients with headache and COVID-19: a pilot, CASE-control, study on 104 patients. J Headache Pain. 2021;22(1):51.CrossRefPubMedPubMedCentral Trigo J, et al. Cytokine and interleukin profile in patients with headache and COVID-19: a pilot, CASE-control, study on 104 patients. J Headache Pain. 2021;22(1):51.CrossRefPubMedPubMedCentral
23.
go back to reference Caronna E, et al. Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: a comprehensive review. Cephalalgia. 2023;43(1):3331024221131337.CrossRefPubMed Caronna E, et al. Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: a comprehensive review. Cephalalgia. 2023;43(1):3331024221131337.CrossRefPubMed
24.
go back to reference Shahid S, et al. Post-vaccination (COVID-19) impacts in healthcare personnel. Pak J Pharm Sci. 2021;34(5Supplementary):1957–62.PubMed Shahid S, et al. Post-vaccination (COVID-19) impacts in healthcare personnel. Pak J Pharm Sci. 2021;34(5Supplementary):1957–62.PubMed
25.
go back to reference Ramasamy MN, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2021;396(10267):1979–93.CrossRefPubMed Ramasamy MN, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2021;396(10267):1979–93.CrossRefPubMed
26.
go back to reference Baden LR, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–16.CrossRefPubMed Baden LR, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–16.CrossRefPubMed
27.
go back to reference Polack FP, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–15.CrossRefPubMed Polack FP, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–15.CrossRefPubMed
28.
go back to reference Yesuf EA, et al. Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: a cross-sectional study. Front Public Health. 2022;10:937794.CrossRefPubMedPubMedCentral Yesuf EA, et al. Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: a cross-sectional study. Front Public Health. 2022;10:937794.CrossRefPubMedPubMedCentral
29.
go back to reference Valencia BM, et al. The severity of the pathogen-induced acute sickness response is affected by polymorphisms in genes of the NLRP3 inflammasome pathway. Brain Behav Immun. 2021;93:186–93.CrossRefPubMedPubMedCentral Valencia BM, et al. The severity of the pathogen-induced acute sickness response is affected by polymorphisms in genes of the NLRP3 inflammasome pathway. Brain Behav Immun. 2021;93:186–93.CrossRefPubMedPubMedCentral
30.
go back to reference He W, et al. Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model. J Neuroinflammation. 2019;16(1):78.CrossRefPubMedPubMedCentral He W, et al. Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model. J Neuroinflammation. 2019;16(1):78.CrossRefPubMedPubMedCentral
31.
go back to reference Suwanwela NC, et al. Prolonged migraine aura resembling ischemic stroke following CoronaVac vaccination: an extended case series. J Headache Pain. 2022;23(1):13.CrossRefPubMedPubMedCentral Suwanwela NC, et al. Prolonged migraine aura resembling ischemic stroke following CoronaVac vaccination: an extended case series. J Headache Pain. 2022;23(1):13.CrossRefPubMedPubMedCentral
32.
go back to reference Garces KN, et al. Headache after vaccination: an update on recent clinical trials and real-world reporting. Curr Pain Headache Rep. 2022;26(12):895–918.CrossRefPubMedPubMedCentral Garces KN, et al. Headache after vaccination: an update on recent clinical trials and real-world reporting. Curr Pain Headache Rep. 2022;26(12):895–918.CrossRefPubMedPubMedCentral
33.
go back to reference Straube A, Ruscheweyh R, Klonowski T. Headache associated with COVID-19 vaccination: how to classify?. Schmerz. 2023:1–9. Straube A, Ruscheweyh R, Klonowski T. Headache associated with COVID-19 vaccination: how to classify?. Schmerz. 2023:1–9.
Metadata
Title
Questionnaire-based study of COVID-19 vaccination induced headache: evidence of clusters of adverse events
Authors
Qiao Zhou
Thomas Eggert
Ana Zhelyazkova
Alexander Choukér
Kristina Adorjan
Andreas Straube
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2024
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-024-03583-6

Other articles of this Issue 1/2024

BMC Neurology 1/2024 Go to the issue